What You Need to Know About the CDC's New Director, Dr. Erica Schwartz

The US Senate confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention on August 5, 2026. The vote was 51-44, mostly split along party lines, meaning Republicans largely voted yes and Democrats largely voted no (The Hill). Schwartz, 54, becomes the 22nd leader of the Atlanta-based agency (Sun-Sentinel) and the first permanent CDC director since Susan Monarez left the role (The Guardian).
The CDC is the federal agency that works to protect Americans from disease outbreaks and other health threats. Getting a new director in place matters because the agency sets national guidance on things like vaccines, food safety, and how to respond to public health emergencies.
Schwartz was President Donald Trump's third pick for the job. The first nominee, former Florida congressman David Weldon, was pulled by the White House in March 2025 just before his confirmation hearing was set to begin. Trump's second choice, Susan Monarez, was fired by Health and Human Services Secretary Robert F. Kennedy Jr. in 2025 after less than a month on the job. The reason: a disagreement over vaccine policy (The Guardian). Schwartz's nomination was formally listed under Senate designation PN932-119, naming her as a Florida resident to serve as CDC Director vice Susan Monarez (Senate HELP Committee).
A Senate committee held Schwartz's confirmation hearing on July 15, 2026 (Senate HELP Committee). At that hearing, senators asked Schwartz whether she would push back if the health secretary pressured her to weaken the scientific agreement on vaccines. She replied that she "will never betray the science" (The Guardian). That question mattered because Monarez had been fired over vaccine policy differences with Kennedy. Schwartz also said during the confirmation process that Kennedy "will absolutely allow me to be CDC director" (The Guardian).
The vote showed how divided politics has become around public health appointments. Senator Tim Kaine of Virginia was the only Democrat to vote yes (The Guardian). On the Republican side, Senator Bill Cassidy of Louisiana, a doctor who leads the Senate committee that held the hearing, announced his support for the nomination (The Guardian). Before the final vote, the Senate held a cloture vote, which is a procedural step to end debate and move forward to a decision (Senate Daily Press.
Schwartz has spent her career in public health service. She served as deputy surgeon general during Trump's first term. She is a Navy veteran who served in the US Public Health Service assigned to the Coast Guard, where she became the force's chief medical officer (The Guardian).
Her military background sets her apart from the two earlier nominees. Weldon was a former congressman known for his work on vaccine safety legislation. Monarez lost her job because Kennedy stepped in directly, and Kennedy's own views on vaccines have been controversial within the public health community. Schwartz's promise to protect scientific integrity, along with her claim that Kennedy would let her do the job independently, made her someone who could satisfy both a White House that wanted loyalty and a Senate worried about politics interfering with the CDC.
The bigger picture is that the CDC has gone a long stretch without a confirmed leader, during a period of real political turbulence. The agency cycled through three nominees in about eighteen months before Schwartz was confirmed. That string of withdrawals and dismissals shows how tangled the CDC director's job has become with broader arguments about vaccine policy, the agency's independence, and the relationship between career scientists and political leaders at the Department of Health and Human Services. Schwartz's confirmation gives the agency a permanent director again, but the conditions she described at her hearing, an HHS secretary whose vaccine stance led to her predecessor's firing, will shape the environment she works in.


